Hematopoietic Growth Factors and Chronic Stroke

造血生长因子与慢性中风

基本信息

  • 批准号:
    8022896
  • 负责人:
  • 金额:
    $ 31.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Stroke, a neurological disorder with a high incidence in the elderly, is a leading cause of long-term disability in adults worldwide. Stroke is also an enormous public health problem and a serious public financial burden in the United States. Chronic stroke is identified as the period beyond 3-6 months after stroke onset. Currently, no pharmaceutical treatment is available for chronic stroke victims. Stem cell factor (SCF) and granulocyte- colony stimulating factor (G-CSF) are hematopoietic growth factors (HGFs) that regulate blood cell production and mobilize bone marrow stem cells (BMSCs) into the blood. Our recent publications have shown that the receptors for SCF and G-CSF are expressed by neurons, that both SCF and G-CSF can pass through the blood-brain barrier, and, more importantly, that SCF in combination with G-CSF (SCFCSF) shows therapeutic benefits for chronic stroke in a rat model of stroke. However, it remains entirely unknown how SCFCSF repairs a permanently damaged brain during chronic stroke. The objective of this project is to address this unanswered question. Supported by considerable preliminary data, the central hypothesis is that neuronal network remodeling contributes to SCFCSF-induced functional recovery in chronic stroke and that the neuronal network remodeling is accomplished by the direct effects of SCFCSF on neurons and the indirect effects via BMSCs. Using neuronal and BMSC cultures together with stroke models in aged spontaneously hypertensive rats and in aged wild type or transgenic C57 BL mice expressing yellow or cyan fluorescent proteins only in neurons (Thy-1-YFP, Thy-1-CFP), and bone marrow transplantation to track BMSCs, this hypothesis will be tested by pursuing two specific aims. Aim #1 is to determine whether SCF CSF-induced functional benefits in chronic stroke are dependent upon MEK/ERK and PI3k/Akt pathway- mediated neuronal network remodeling. Western blots, cell signaling blockade, RNA interference, 2-photon live imaging and neurological deficit examinations will be used. Aim #2 is to identify the role of the S100A8/A9 chemical gradient established by SCFCSF in homing BMSCs to the brain and to determine the contribution of the BMSCs to SCFCSF-induced functional recovery from chronic stroke. BMSC migration assays, S100A8/A9 gene silencing by RNA interference, and sensorimotor functional evaluation will be utilized. The proposed research is significant because it will advance and extend understanding of how HGFs repair the brain after permanent damage by stroke. Additionally, it will significantly contribute to the development of a unique therapeutic strategy for treatment of chronic stroke. This contribution is in keeping with the NIH mission to reduce national and personal burdens caused by illness and disability. PUBLIC HEALTH RELEVANCE: The proposed study focuses on a highly important, but under-investigated topic: a new therapeutic strategy to treat chronic stroke in the aged population. This research is directly relevant to public health. The findings can provide fresh insights into the contribution of hematopoietic growth factors in brain repair. Additionally, this knowledge may also lead to the development of new treatments for other neurological disorders and neurodegenerative diseases.
描述(申请人提供):中风是一种在老年人中发病率较高的神经疾病,是全球成年人长期残疾的主要原因。在美国,中风也是一个巨大的公共卫生问题和严重的公共经济负担。慢性卒中是指卒中发病后3-6个月以上的时间。目前,慢性中风患者还没有药物治疗。干细胞因子(SCF)和粒细胞集落刺激因子(G-CSF)是调节血细胞生成和动员骨髓干细胞(BMSCs)进入血液的造血生长因子(HGFs)。我们最近的研究表明,SCF和G-CSF的受体是由神经元表达的,SCF和G-CSF都可以通过血脑屏障,更重要的是,SCF和G-CSF联合应用对卒中大鼠模型显示出治疗效果。然而,SCFCSF如何修复慢性中风期间永久性受损的大脑仍是完全未知的。这个项目的目标是解决这个悬而未决的问题。有大量的初步数据支持,中心假说是,神经元网络重构有助于SCFCSF诱导的慢性卒中功能恢复,神经元网络重构是通过SCFCSF对神经元的直接作用和通过骨髓间充质干细胞的间接作用完成的。在老年自发性高血压大鼠和仅在神经元中表达黄色或青色荧光蛋白的老年野生型或转基因C57BL小鼠(Thy-1-YFP,Thy-1-CFP)中,神经元和BMSC培养与中风模型一起使用,以及骨髓移植跟踪BMSCs,这一假设将通过追求两个特定目标来验证。目的1确定SCF-CSF对慢性卒中患者的功能益处是否依赖于MEK/ERK和PI3K/Akt通路介导的神经元网络重构。将使用蛋白质印迹、细胞信号阻断、RNA干扰、双光子实时成像和神经功能缺陷检查。目的#2确定SCFCSF建立的S100A8/A9化学梯度在BMSCs归巢到脑中的作用,并确定BMSCs在SCFCSF诱导的慢性卒中功能恢复中的作用。骨髓间充质干细胞迁移分析、S100A8/A9基因RNA干扰沉默和感觉运动功能评估将被用于。这项拟议的研究意义重大,因为它将促进和扩大对HGFs如何在中风造成永久性损伤后修复大脑的理解。此外,它还将为开发一种治疗慢性中风的独特治疗策略做出重大贡献。这一贡献符合美国国立卫生研究院减轻疾病和残疾造成的国家和个人负担的使命。 公共卫生相关性:拟议的研究集中在一个非常重要但调查不足的主题上:一种治疗老年人群慢性中风的新治疗策略。这项研究与公共健康直接相关。这一发现可以为造血生长因子在脑修复中的作用提供新的见解。此外,这一知识还可能导致开发其他神经疾病和神经退行性疾病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LI-RU ZHAO其他文献

LI-RU ZHAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LI-RU ZHAO', 18)}}的其他基金

Exploring mechanisms underlying SCF+G-CSF-enhanced recovery in chronic TBI.
探索 SCF G-CSF 增强慢性 TBI 恢复的潜在机制。
  • 批准号:
    10741338
  • 财政年份:
    2023
  • 资助金额:
    $ 31.41万
  • 项目类别:
Exploring Mechanisms Underlying SCF+G-CSF-Enhanced Recovery in ChronicTBI
探索 SCF G-CSF 增强慢性 TBI 恢复的机制
  • 批准号:
    10810929
  • 财政年份:
    2021
  • 资助金额:
    $ 31.41万
  • 项目类别:
Exploring mechanisms underlying SCF+G-CSF-enhanced recovery in chronicTBI.
探索 SCF G-CSF 增强慢性 TBI 恢复的机制。
  • 批准号:
    10376341
  • 财政年份:
    2021
  • 资助金额:
    $ 31.41万
  • 项目类别:
Revealing novel pathogenic and repairing mechanisms of CADASIL disease.
揭示 CADASIL 疾病的新致病和修复机制。
  • 批准号:
    10419211
  • 财政年份:
    2021
  • 资助金额:
    $ 31.41万
  • 项目类别:
Exploring mechanisms underlying SCF+G-CSF-enhanced recovery in chronic TBI.
探索 SCF G-CSF 增强慢性 TBI 恢复的潜在机制。
  • 批准号:
    10220357
  • 财政年份:
    2021
  • 资助金额:
    $ 31.41万
  • 项目类别:
Exploring Mechanisms Underlying SCF+G-CSF-Enhanced Recovery in ChronicTBI
探索 SCF G-CSF 增强慢性 TBI 恢复的机制
  • 批准号:
    10605216
  • 财政年份:
    2021
  • 资助金额:
    $ 31.41万
  • 项目类别:
Targeting the hematopoietic system: the role of hematopoietic growth factors in restricting A-beta accumulation in Alzheimers disease
靶向造血系统:造血生长因子在限制阿尔茨海默病中 A-β 积累中的作用
  • 批准号:
    9377021
  • 财政年份:
    2016
  • 资助金额:
    $ 31.41万
  • 项目类别:
Targeting the hematopoietic system: the role of hematopoietic growth factors in restricting A-beta accumulation in Alzheimers disease
靶向造血系统:造血生长因子在限制阿尔茨海默病中 A-β 积累中的作用
  • 批准号:
    9357507
  • 财政年份:
    2016
  • 资助金额:
    $ 31.41万
  • 项目类别:
Hematopoietic Growth Factors and Chronic Stroke
造血生长因子与慢性中风
  • 批准号:
    8447001
  • 财政年份:
    2010
  • 资助金额:
    $ 31.41万
  • 项目类别:
Hematopoietic Growth Factors and Chronic Stroke
造血生长因子与慢性中风
  • 批准号:
    8247103
  • 财政年份:
    2010
  • 资助金额:
    $ 31.41万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.41万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了